FDA NDC Directory · JSON-LD · Markdown

Regadenoson

NDC 0641-6253 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerHikma Pharmaceuticals USA Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA215827
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsREGADENOSON ANHYDROUS (.08 mg/mL)
Marketing started20230403
Package count1

External sources

Source: openFDA. Public-domain (CC0).